小儿低级别胶质瘤的磁共振成像:无神经纤维瘤病 1 患者中 V600E 突变、融合和野生型肿瘤的治疗前鉴别。
MR Imaging of Pediatric Low-Grade Gliomas: Pretherapeutic Differentiation of V600E Mutation, Fusion, and Wild-Type Tumors in Patients without Neurofibromatosis-1.
机构信息
From the IWK Health Centre (A.T., C.E., C.C., K.M., D.M.-M.), Halifax, Nova Scotia, Canada.
Dalhousie University Medical School (A.T.), Halifax, Nova Scotia, Canada.
出版信息
AJNR Am J Neuroradiol. 2022 Aug;43(8):1196-1201. doi: 10.3174/ajnr.A7574. Epub 2022 Jul 21.
BACKGROUND AND PURPOSE
The prognosis and treatment of pediatric low-grade gliomas is influenced by their molecular subtype. MR imaging remains the mainstay for initial work-up and surgical planning. We aimed to determine the relationship between imaging patterns and molecular subtypes of pediatric low-grade gliomas.
MATERIALS AND METHODS
This was a retrospective bi-institutional study for patients diagnosed from 2004 to 2021 with pathologically confirmed pediatric low-grade gliomas molecularly defined as fusion, V600E mutant, or wild-type (which is neither V600E mutant nor fusion). Two neuroradiologists, blinded, independently reviewed imaging parameters from diagnostic MRIs, and discrepancies were resolved by consensus. Bivariate analysis was used followed by pair-wise comparison of the Dwass-Steel-Critchlow-Fligner method to compare the 3 molecular subtypes. Interreader agreement was assessed using κ.
RESULTS
We included 70 patients: 30 fusion, 19 V600E mutant, and 21 wild-type. There was substantial agreement between the readers for overall imaging variables (κ = 0.75). fusion tumors compared with V600E and wild-type tumors were larger ( = .0022), and had a greater mass effect ( = .0053), increased frequency of hydrocephalus ( = .0002), and diffuse enhancement ( <.0001). V600E mutant tumors were more often hemispheric (< .0001), appeared more infiltrative ( = .0002), and, though infrequent, were the only group demonstrating diffusion restriction (qualitatively; = .0042) with a lower ADC ratio (quantitatively) ( = .003).
CONCLUSIONS
fusion and V600E mutant pediatric low-grade gliomas have unique imaging features that can be used to differentiate them from each other and wild-type pediatric low-grade glioma using a standard radiology review with high interreader agreement. In the era of targeted therapy, these features can be useful for therapeutic planning before surgery.
背景与目的
小儿低级别胶质瘤的预后和治疗受其分子亚型的影响。磁共振成像仍然是初始检查和手术计划的主要手段。我们旨在确定小儿低级别胶质瘤的影像学表现与分子亚型之间的关系。
材料与方法
这是一项回顾性的双机构研究,纳入了 2004 年至 2021 年间经病理证实的小儿低级别胶质瘤患者,这些患者的分子特征为 融合、V600E 突变或野生型(既不是 V600E 突变也不是 融合)。两名神经放射科医生独立盲法分析诊断性磁共振成像的影像学参数,通过共识解决分歧。采用双变量分析,然后使用 Dwass-Steel-Critchlow-Fligner 方法进行两两比较,以比较 3 种分子亚型。采用κ检验评估读者间的一致性。
结果
共纳入 70 例患者:30 例为 融合,19 例为 V600E 突变,21 例为野生型。两位读者在整体影像学变量方面具有高度一致性(κ=0.75)。与 V600E 突变型和野生型肿瘤相比, 融合肿瘤体积更大( =.0022),占位效应更明显( =.0053),脑积水发生率更高( =.0002),弥漫性强化更常见( <.0001)。V600E 突变型肿瘤更常位于半球( < .0001),侵袭性更强( =.0002),尽管少见,但也是唯一表现出弥散受限(定性)( =.0042)和 ADC 比值降低(定量)( =.003)的组别。
结论
融合和 V600E 突变型小儿低级别胶质瘤具有独特的影像学特征,使用标准放射学审查,具有高度的读者间一致性,可将其彼此区分,并与野生型小儿低级别胶质瘤相区分。在靶向治疗时代,这些特征对于手术前的治疗计划非常有用。